Your browser doesn't support javascript.
loading
Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients.
Keung, Benison; Robeson, Kimberly R; DiCapua, Daniel B; Rosen, Jennifer B; O'Connor, Kevin C; Goldstein, Jonathan M; Nowak, Richard J.
Affiliation
  • Keung B; Department of Neurology, Yale University School of Medicine, , New Haven, Connecticut, USA.
J Neurol Neurosurg Psychiatry ; 84(12): 1407-9, 2013 Dec.
Article in En | MEDLINE | ID: mdl-23761915
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Receptors, Cholinergic / Receptor Protein-Tyrosine Kinases / Antibodies, Monoclonal, Murine-Derived / Myasthenia Gravis Type of study: Observational_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Receptors, Cholinergic / Receptor Protein-Tyrosine Kinases / Antibodies, Monoclonal, Murine-Derived / Myasthenia Gravis Type of study: Observational_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido